Lv66
2370 积分 2024-08-19 加入
ACR Appropriateness Criteria® Management of Uterine Fibroids: 2023 Update
2个月前
已完结
Chinese guidelines for the rehabilitation treatment of knee osteoarthritis: An CSPMR evidence‐based practice guideline
2个月前
已完结
Neuropathic pain: From actual pharmacological treatments to new therapeutic horizons
3个月前
已完结
Long-Term Survival Outcomes with Intravesical Docetaxel for Recurrent Nonmuscle Invasive Bladder Cancer After Previous Bacillus Calmette-Guérin Therapy
3个月前
已完结
IL-15 Superagonist NAI in BCG-Unresponsive Non–Muscle-Invasive Bladder Cancer
3个月前
已完结
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
3个月前
已完结
Sequential Treatment With Bacillus Calmette-Güerin (BCG) and Mitomycin C Administered With Electromotive Drug Administration (EMDA) in Patients With High-Risk Nonmuscle Invasive Bladder Cancer After BCG Failure
3个月前
已完结
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
3个月前
已完结
International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin–exposed High-risk Non–muscle-invasive Bladder Cancer
3个月前
已完结
The role of pre- and postnatal investigations in suspected isolated hypospadias
3个月前
已完结
皖公网安备34019202002308
